117 related articles for article (PubMed ID: 10359892)
1. IL-1 receptor-type expression in relation to atopy.
Gupta K; Bewtra A
J Allergy Clin Immunol; 1999 Jun; 103(6):1100-7. PubMed ID: 10359892
[TBL] [Abstract][Full Text] [Related]
2. Elevated levels of soluble interleukin-1 receptor type II and interleukin-1 receptor antagonist in patients with chronic arthritis: correlations with markers of inflammation and joint destruction.
Jouvenne P; Vannier E; Dinarello CA; Miossec P
Arthritis Rheum; 1998 Jun; 41(6):1083-9. PubMed ID: 9627018
[TBL] [Abstract][Full Text] [Related]
3. Binding of IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids.
Arend WP; Malyak M; Smith MF; Whisenand TD; Slack JL; Sims JE; Giri JG; Dower SK
J Immunol; 1994 Nov; 153(10):4766-74. PubMed ID: 7963543
[TBL] [Abstract][Full Text] [Related]
4. [Concentration of interleukin-18, interleukin-1beta, soluble receptor for interleukin-1 (sIL-1RII) and C-reactive protein in patients with neuroborreliosis].
Pietruczuk A; Swierzbińska R; Pietruczuk M; Kondrusik M; Zajkowska J; Pancewicz S; Hermanowska-Szpakowicz T
Neurol Neurochir Pol; 2005; 39(1):33-9. PubMed ID: 15735988
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-1 receptor accessory protein interacts with the type II interleukin-1 receptor.
Malinowsky D; Lundkvist J; Layé S; Bartfai T
FEBS Lett; 1998 Jun; 429(3):299-302. PubMed ID: 9662436
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-1 receptor mRNA expression in activated bovine leukocytes in vitro.
Yu PW; Schuler LA; Czuprynski CJ
Clin Diagn Lab Immunol; 1997 Nov; 4(6):769-73. PubMed ID: 9384305
[TBL] [Abstract][Full Text] [Related]
7. Profile of soluble cytokine receptors in Crohn's disease.
Gustot T; Lemmers A; Louis E; Nicaise C; Quertinmont E; Belaiche J; Roland S; Van Gossum A; Devière J; Franchimont D
Gut; 2005 Apr; 54(4):488-95. PubMed ID: 15753533
[TBL] [Abstract][Full Text] [Related]
8. Soluble interleukin-1 receptor, a potential negative regulator of orange-spotted grouper Epinephelus coioides interleukin-1 system.
Lu DQ; Yao M; Yi SB; Li YW; Liu XC; Zhang Y; Lin HR
J Fish Biol; 2013 Sep; 83(3):642-58. PubMed ID: 23991879
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-1 (IL-1alpha and IL-1beta) and its receptors (IL-1RI, IL-1RII, and IL-1Ra) in prostate carcinoma.
Ricote M; García-Tuñón I; Bethencourt FR; Fraile B; Paniagua R; Royuela M
Cancer; 2004 Apr; 100(7):1388-96. PubMed ID: 15042672
[TBL] [Abstract][Full Text] [Related]
10. [Role of interleukin-18, interleukin-1beta and its soluble receptor (sIL-1RII) in early and late Lyme borreliosis].
Pietruczuk A; Swierzbińska R; Pietruczuk M; Hermanowska-Szpakowicz T
Pol Merkur Lekarski; 2004 Nov; 17(101):446-50. PubMed ID: 15754629
[TBL] [Abstract][Full Text] [Related]
11. Reversal of autocrine and paracrine effects of interleukin 1 (IL-1) in human arthritis by type II IL-1 decoy receptor. Potential for pharmacological intervention.
Attur MG; Dave M; Cipolletta C; Kang P; Goldring MB; Patel IR; Abramson SB; Amin AR
J Biol Chem; 2000 Dec; 275(51):40307-15. PubMed ID: 11007768
[TBL] [Abstract][Full Text] [Related]
12. Characterization of IL-1β and two types of IL-1 receptors in miiuy croaker and evolution analysis of IL-1 family.
Yang Q; Chu Q; Zhao X; Xu T
Fish Shellfish Immunol; 2017 Apr; 63():165-172. PubMed ID: 28189765
[TBL] [Abstract][Full Text] [Related]
13. Differential regulation of type I and type II interleukin-1 receptors in focal brain inflammation.
Docagne F; Campbell SJ; Bristow AF; Poole S; Vigues S; Guaza C; Perry VH; Anthony DC
Eur J Neurosci; 2005 Mar; 21(5):1205-14. PubMed ID: 15813930
[TBL] [Abstract][Full Text] [Related]
14. Molecular characterization and functional expression of equine interleukin-1 type I and type II receptor cDNAs.
Kirisawa R; Hashimoto N; Tazaki M; Yamanaka H; Ishii R; Hagiwara K; Iwai H
Vet Immunol Immunopathol; 2006 Feb; 109(3-4):219-31. PubMed ID: 16176839
[TBL] [Abstract][Full Text] [Related]
15. IL-1beta, IL-1Ra and sIL-1RII in the culture supernatants of PMN and PBMC and the serum levels in patients with inflammation and patients with cancer disease of the same location.
Jablonska E; Jablonski J; Piotrowski L; Grabowska Z
Immunobiology; 2001 Dec; 204(4):508-16. PubMed ID: 11776404
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticoid sensitivity of interleukin-1 agonist and antagonist secretion: the effects of age and gender.
Daun JM; Ball RW; Cannon JG
Am J Physiol Regul Integr Comp Physiol; 2000 Apr; 278(4):R855-62. PubMed ID: 10749772
[TBL] [Abstract][Full Text] [Related]
17. Effect of IL-18 on IL-1beta and sIL-1RII production by human neutrophils.
Jabłońska E; Izycka A; Wawrusiewicz N
Arch Immunol Ther Exp (Warsz); 2002; 50(2):139-41. PubMed ID: 12022703
[TBL] [Abstract][Full Text] [Related]
18. The membrane form of the type II IL-1 receptor accounts for inhibitory function.
Neumann D; Kollewe C; Martin MU; Boraschi D
J Immunol; 2000 Sep; 165(6):3350-7. PubMed ID: 10975853
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of interleukin-18 (IL-18), interleukin-1beta (IL-1beta), its soluble receptor sIL-1RII and C-reactive protein (CRP) in patients with Lyme arthritis.
Pietruczuk A; Swierzbińska R; Pancewicz S; Pietruczuk M; Hermanowska-Szpakowicz T
Infection; 2006 Jun; 34(3):158-62. PubMed ID: 16804660
[TBL] [Abstract][Full Text] [Related]
20. The type II IL-1 receptor interacts with the IL-1 receptor accessory protein: a novel mechanism of regulation of IL-1 responsiveness.
Lang D; Knop J; Wesche H; Raffetseder U; Kurrle R; Boraschi D; Martin MU
J Immunol; 1998 Dec; 161(12):6871-7. PubMed ID: 9862719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
